To The Moon

$Illumina(ILMN)$

$Illumina(ILMN) Closes +1.18% at $193.14 — Genomic Leader Reclaims Momentum, $196 Resistance Now in Focus

Latest Close Data ILMN settled at $193.14 (+1.18%) on 2026-08-18, just 6.7% below its 52-week high of $207.00. After-hours action firmed to $193.34, hinting at mild continuation demand.

Core Market Drivers Illumina's July Q2 beat (EPS $1.31 vs $1.23 est; revenue $11.59B vs $11.30B) and raised FY guidance ($4.52–$4.62B) continue to anchor sentiment. RBC lifted its target to $230, reinforcing institutional conviction in the genomics franchise.

Technical Analysis Volume was 996K shares with a Volume Ratio of 0.85 — below-average participation, so the rally lacks full confirmation. RSI(6) recovered to 48.91 from 40.28, exiting oversold territory. MACD remains negative (DIF 2.17 vs DEA 3.68), showing bearish momentum is fading but a bullish crossover has not yet printed. KDJ shows K(32.29) still below D(34.33), with J rising to 28.21 — early stabilization.

Key Price Levels

• Primary Support: $151.28 (08-14 swing low)

• Strong Resistance: $196.09 (08-14 pivot high)

• Immediate Pivot: $193.85 (today's high) — a close above this opens the door to retest $207.

Valuation Perspective P/E TTM stands at 35.96, while Forward P/E is 35.67 — slightly below the historical average of 64.98, reflecting improved earnings expectations. P/S TTM is 6.49, and P/B is 10.28, suggesting growth is still priced at a premium but far less stretched than past cycles.

Analyst Targets 19 analysts cover ILMN with an average target of $193.95. Ratings: 5 Strong Buy, 6 Buy, 8 Hold, 2 Underperform, 1 Sell. The consensus target sits just above current price, implying modest upside.

Weekly Outlook Expect a range of $188–$198. A decisive break above $196.09 could trigger a move toward $207.00 (52-week high). Failure to hold $188.94 (today's low) risks a retest of $180–$182 support. Watch for MACD bullish crossover confirmation next week.

⚠️ This is a technical analysis based on historical data and indicators, not financial advice. Markets involve risk — always do your own research before trading.

🎯$Illumina(ILMN) Options Strategy: Bull Call Spread

• Underlying: Illumina (ILMN)

• View: Cautiously bullish — oversold rebound with resistance at $196.09; RSI recovering from oversold but MACD bullish crossover not yet confirmed; below-average volume suggests conviction is building but not yet confirmed.

• Strategy Type: Debit Spread (Bull Call Spread)

• Option Contract Portfolio:

  • Buy 1x ILMN 2026-09-18 Call @ $195 Strike (Mid: $8.20)

  • Sell 1x ILMN 2026-09-18 Call @ $210 Strike (Mid: $4.175)

  • Expiration: 2026-09-18 (31 DTE)

• Max Gain & Loss:

  • Max Gain: $1,097.50 per spread (Width $15 − Net Debit $4.025 = $10.975 × 100 shares)

  • Max Loss: $402.50 per spread (Net Debit $4.025 × 100 shares)

• Initial Cost/Credit: Net Debit of $4.025 per share ($402.50 per spread)

🐯🪙 Share your choice and reasoning in the comments — thoughtful views may receive Tiger Coins!

Good allocation isn’t just about investing — it’s also about keeping everyday life organised.

Just like a well-balanced portfolio, the right organisation can make business trips, travel and workouts a little easier. The new Tiger Toiletry Bag features a dual-layer dry & wet separation design with plenty of space to keep your essentials neatly organised, wherever you go.

Redeem the new Tiger Toiletry Bag now in Tiger Coin Mall. https://laohu8.com/J/redeemGift?goodID=100538&type=delivery